Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SANDRA M EL-HACHEM

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1851583108
CMS profile
39406
Location
PITTSBURGH, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$102,680.35

63 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $40,101.58 23
Takeda Pharmaceuticals U.S.A., Inc. $22,888.43 10
ABBVIE INC. $20,333.34 15
PFIZER INC. $13,778.36 9
E.R. Squibb & Sons, L.L.C. $4,961.67 4
Celgene Corporation $600.00 1
GENZYME CORPORATION $16.97 1

Page 2 of 2; records 51–63 of 63 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SANDRA M EL-HACHEM

NPI 1851583108 · CMS profile ID 39406

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

PITTSBURGH, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–63 of 63 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851583108?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SANDRA M EL-HACHEM, NPI 1851583108, CMS profile ID 39406. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–63 of 63 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851583108?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SANDRA M EL-HACHEM, NPI 1851583108, CMS profile ID 39406. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–63 of 63 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851583108?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SANDRA M EL-HACHEM, NPI 1851583108, CMS profile ID 39406, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–63 of 63 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1851583108?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

63 matching records · $102,680.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 63 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–63 of 63.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $821.2804/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131555498 CMS
PFIZER INC. $4,275.0003/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131555502 CMS
PFIZER INC. $86.9903/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131555505 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5,874.3803/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137538817 CMS
ABBVIE INC. $124.9903/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103683427 CMS
ABBVIE INC. $706.8803/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104184296 CMS
Janssen Biotech, Inc. $6,300.0003/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078591397 CMS
ABBVIE INC. $3,500.0003/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103149047 CMS
Janssen Biotech, Inc. $906.0003/12/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078589683 CMS
Janssen Biotech, Inc. $130.2903/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078592297 CMS
ABBVIE INC. $103.1602/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103683425 CMS
Takeda Pharmaceuticals U.S.A., Inc. $121.3602/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137538813 CMS
ABBVIE INC. $27.9901/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103683423 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $48,909.60 50
PY2020 $19,029.32 19
PY2021 $49,530.17 38
PY2022 $66,494.51 64
PY2023 $30,405.00 56
PY2024 $102,680.35 63
PY2025 $154,964.10 90

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $34,399.70 40
PY2024 Principal investigator $239,211.60 40
PY2023 Principal investigator $46,297.50 12
PY2022 Principal investigator $6,500.00 2
PY2020 Principal investigator $1,640.00 2
PY2019 Principal investigator $17,430.78 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

40 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 12/12/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263518
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 12/12/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263520
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 12/12/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263522
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 12/12/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263524
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 10/08/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263492
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 10/08/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263494
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 10/08/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263496
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 08/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263478
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,000.00 08/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263480
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 07/23/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263474
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 07/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263470
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 07/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263472
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 06/06/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263462
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 06/06/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263464
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 06/06/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263466
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 05/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263460
Principal investigator 1 ABBVIE INC. $1,200.00 05/06/2025 Non-covered Recipient Entity
ALLEGHENY SINGER RESEARCH INSTITUTE
Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis No dispute reported 06/30/2026 1202481441
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $400.00 04/07/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263456
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 03/12/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263454
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 03/03/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263452
Principal investigator 1 ABBVIE INC. $1,005.40 02/11/2025 Non-covered Recipient Entity
ALLEGHENY SINGER RESEARCH INSTITUTE
M21-446 - Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis No dispute reported 06/30/2026 1202450519
Principal investigator 1 ABBVIE INC. $2,560.00 02/06/2025 Non-covered Recipient Entity
ALLEGHENY SINGER RESEARCH INSTITUTE
M21-446 - Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis No dispute reported 06/30/2026 1202448186
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,000.00 01/17/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263442
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,500.00 01/17/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263444
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $400.00 01/17/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263446
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $387.00 01/08/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL No dispute reported 06/30/2026 1223263440
Principal investigator 1 ABBVIE INC. $92.30 01/02/2025 Non-covered Recipient Entity
ALLEGHENY SINGER RESEARCH INSTITUTE
M21-446 - Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis No dispute reported 06/30/2026 1202434622
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263414
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263416
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263418
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263420
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263422
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263424
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263426
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263428
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263430
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263432
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263434
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263436
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $850.00 01/02/2025 Covered Recipient Teaching Hospital
ALLEGHENY GENERAL HOSPITAL
A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME No dispute reported 06/30/2026 1223263438